Clinical

Ms. Hester is Content Specialist with Contemporary OB/GYN and Contemporary Pediatrics.

Articles

The CDC has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for COVID-19.

CDC Issues First Recommendations For People Fully Vaccinated for COVID-19

In an opinion piece, pharmacist Pete Kreckel highlights the ways that women have been leading the COVID-19 vaccination effort.

Women Pharmacists Are Leading Successful COVID-19 Vaccination Programs

Here's a roundup of the latest coronavirus-related news.

Coronavirus News Roundup: FDA Authorizes Johnson & Johnson Vaccine; Biden Pledges Vaccine Supply for All US Adults by End of May 

In a briefing this morning, the Infectious Diseases Society of America (IDSA) stressed the continued importance of COVID-19 control measures that have been there from the start.

IDSA: COVID-19 Testing, Masking Still Needed to Control Pandemic

Jon Copeland, president of AAP, joins Drug Topics® in this episode of Over the Counter to discuss key pharmacy industry trends, including digital health, the Amazon effect, PBM accountability, and pharmacy cooperatives. 

AAP Series: Tips to Reach Your 2021 Business Goals

President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May. 

Biden Pledges Enough COVID-19 Vaccines for All US Adults By End of May

Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.   

Study Results Show Half of Severe COVID-19 Patients Have Damage to the Heart 

The FDA is allowing more flexible storage and transportation conditions for Pfizer-BioNTech’s COVID-19 vaccine. 

FDA Updates Storage, Transportation Guidance for Pfizer-BioNTech COVID-19 Vaccine

The FDA has granted emergency use authorization status for the first single-dose vaccine for COVID-19 in the United States.

FDA Grants Emergency Use Authorization to Third COVID-19 Vaccine

On Friday, a panel of advisors to the FDA voted to recommend Johnson & Johnson's COVID-19 vaccine, named Ad26.COV2.S, for emergency approval.